RSNA 2014 

Abstract Archives of the RSNA, 2014


SSK16-09

Is Diffusion Kurtosis a New Biomarker to Assess the Vulnerable Brain Structure in Alzheimer's Disease?

Scientific Papers

Presented on December 3, 2014
Presented as part of SSK16: Neuroradiology (Advanced Neuroimaging of Alzheimer's Disease)

Participants

Yanwei Miao, Presenter: Nothing to Disclose
Rui Hu MS, Abstract Co-Author: Nothing to Disclose
Wei-Wei Wang MD, PhD, Abstract Co-Author: Nothing to Disclose
Bingbing Gao, Abstract Co-Author: Nothing to Disclose
shiyun tian, Abstract Co-Author: Nothing to Disclose
Minting Zheng, Abstract Co-Author: Nothing to Disclose
He Qing Wang MSc, Abstract Co-Author: Nothing to Disclose

PURPOSE

As a kind of degeneration diseases, Alzheimer’s disease (AD) progressively involves into the different brain regions in turn. The measurement of brain region volume is up to date a structure biomarker for AD, but it is not used widely based on inconvenient process. This study is to exploit the ability of diffusion kurtosis imaging (DKI) on the detection of brain structure vulnerability in AD.

METHOD AND MATERIALS

Twenty three cases of clinically confirmed AD and Twenty four age- and sex-matched healthy volunteers underwent conventional MRI scan and DKI scanning on a 3.0T MR imaging scanner. The bilateral MK values, Ka values, Kr values, MD values, Da values, Dr values and FA values of the frontal WM, parietal WM, occipital WM, temporal WM, hippocampus, thalamus, splenium of the corpus callosum, genu of the corpus callosum, trunk of the corpus callosum, anterior limb of the internal capsule, posterior limb of the internal capsule, external capsule, and hemispherium cerebelli were measured manually by two neuroradiologist respectively. Two independent samples t-test was used to compare the mean values of parameters in all brain regions between the AD and healthy groups. Receiver operating characteristic (ROC) test were used to assess the ability of regional diffusion measures to discriminate differences between groups.

RESULTS

There is the high consistency of all DKI data between the two measurers (ICC=0.96). The significant different mean value of MK, Ka, Kr, MD, Da, Dr and FA value were present between AD group and healthy group in all regions, especially in the parietal WM, temporal WM and hippocampus( P<0.05). From ROC analysis, the biggest area under ROC curve (AUC) value of 0.954 belongs to Dr value (0.758) as the cutoff for diagnosing AD in the temporal WM, In turn, the AUC of 0.880, 0.823 and 0.804 was attributed to the Dr value in hippocampus, the MD value in temporal WM and the Dr value in parietal WM.  

CONCLUSION

The temporal WM, hippocampus and parietal WM are the vulnerable brain structures assessed by using DKI parameters.

CLINICAL RELEVANCE/APPLICATION

DKI can quantitatively evaluate microstructure damage in AD patients.

Cite This Abstract

Miao, Y, Hu, R, Wang, W, Gao, B, tian, s, Zheng, M, Wang, H, Is Diffusion Kurtosis a New Biomarker to Assess the Vulnerable Brain Structure in Alzheimer's Disease?.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14013247.html